Paroxetine in panic disorder: clinical management and long-term follow-up

2004 ◽  
Vol 4 (2) ◽  
pp. 191-198 ◽  
Author(s):  
Pinhas N Dannon ◽  
Katherine Lowengrub ◽  
I Iancu ◽  
Moshe Kotler
2004 ◽  
Vol 19 (2) ◽  
pp. 97-101 ◽  
Author(s):  
Pinhas N. Dannon ◽  
Katherine Lowengrub ◽  
Revital Amiaz ◽  
Leon Grunhaus ◽  
Moshe Kotler

2001 ◽  
Vol 25 (3) ◽  
pp. 187-190 ◽  
Author(s):  
Deniz Çetiner ◽  
Umay Engel ◽  
Gülay Tüter ◽  
Mehmet Yalim

The present study describes the characteristics and clinical management of two patients with ectodermal dysplasia with long term follow-up. Dental treatments depend on the severity of disorder, therefore, treatment varies according to the age, growth and development of the stomatognathic system of the patient. It is important that the patient and dentist understand continued monitoring for dental problems is necessary. This provides improved aesthetics, function and emotional development.


1995 ◽  
Vol 166 (1) ◽  
pp. 87-92 ◽  
Author(s):  
Giovanni A. Fava ◽  
Maria Zielezny ◽  
Gianni Savron ◽  
Silvana Grandi

BackgroundThere are few long-term follow-up studies of panic disorder treatments, particularly when patients have been treated by behavioural methods only and have recovered.Method110 consecutive patients satisfying the DSM–III–R criteria for panic disorder with agoraphobia were treated in an out-patient clinic with behavioural methods based on exposure. After 12 sessions of psychotherapy, 81 patients became panic-free. A 2–9 year follow-up was available. Survival analysis was employed to characterise the clinical course of patients. Regular assessments by a clinical psychologist were based on the Clinical Interview for Depression.ResultsThe estimated cumulative percentage of patients remaining in remission was 96.1% for at least two years, 77.6% for at least five years, and 67.4% for at least seven years. These outcomes greatly improved in the absence of a personality disorder or residual agoraphobia after treatment.ConclusionsThe findings suggest that, even though one patient in four is unable to complete treatment or does not benefit sufficiently from it, exposure treatment can provide lasting relief for the majority of patients. Disappearance of residual and subclinical agoraphobic avoidance, and not simply of panic attacks, should be the aim of exposure therapy.


Cardiology ◽  
2008 ◽  
Vol 110 (1) ◽  
pp. 8-14 ◽  
Author(s):  
Christine Bull Bringager ◽  
Harald Arnesen ◽  
Svein Friis ◽  
Trygve Husebye ◽  
Toril Dammen

2021 ◽  
Vol 15 (3) ◽  
pp. e0009191
Author(s):  
Francesca Tamarozzi ◽  
Veronica A. Fittipaldo ◽  
Hans Martin Orth ◽  
Joachim Richter ◽  
Dora Buonfrate ◽  
...  

Background Hepatosplenic schistosomiasis (HSS) is a disease caused by chronic infection with Schistosma spp. parasites residing in the mesenteric plexus; portal hypertension causing gastrointestinal bleeding is the most dangerous complication of this condition. HSS requires complex clinical management, but no specific guidelines exist. We aimed to provide a comprehensive picture of consolidated findings and knowledge gaps on the diagnosis and treatment of HSS. Methodology/principal findings We reviewed relevant original publications including patients with HSS with no coinfections, published in the past 40 years, identified through MEDLINE and EMBASE databases. Treatment with praziquantel and HSS-associated pulmonary hypertension were not investigated. Of the included 60 publications, 13 focused on diagnostic aspects, 45 on therapeutic aspects, and 2 on both aspects. Results were summarized using effect direction plots. The most common diagnostic approaches to stratify patients based on the risk of variceal bleeding included the use of ultrasonography and platelet counts; on the contrary, evaluation and use of noninvasive tools to guide the choice of therapeutic interventions are lacking. Publications on therapeutic aspects included treatment with beta-blockers, local management of esophageal varices, surgical procedures, and transjugular intrahepatic portosystemic shunt. Overall, treatment approaches and measured outcomes were heterogeneous, and data on interventions for primary prevention of gastrointestinal bleeding and on the long-term follow-up after interventions were lacking. Conclusions Most interventions have been developed on the basis of individual groups’ experiences and almost never rigorously compared; furthermore, there is a lack of data regarding which parameters can guide the choice of intervention. These results highlight a dramatic need for the implementation of rigorous prospective studies with long-term follow-up in different settings to fill such fundamental gaps, still present for a disease affecting millions of patients worldwide.


Sign in / Sign up

Export Citation Format

Share Document